Completed PHASE1 INTERVENTIONAL 1-arm NCT01719133

Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen

Détermination de la réactivité cutanée de Volontaires Allergiques au Pollen de Bouleau Contre Des Peptides dérivés de Bet v 1

Sponsor: Anergis

Conditions Allergic Rhinitis

Interventions AllerT1 AllerT2 AllerT3 AllerT4 AllerT5 Histamine mix of AllerT1-T2-T3 mix of AllerT4-T5 placebo

Updated 5 times since 2017 Last updated: Oct 31, 2012 Started: Feb 29, 2008 Primary completion: Mar 31, 2008 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Allergic Rhinitis, this trial is completed. The trial is conducted by Anergis and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anergis

Data source: Anergis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lausanne, Switzerland